Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

NCT04203992 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2020-09-16

No results posted yet for this study

Summary

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to dope. The investigators hypothesize that student athletes who play the intervention game will have lower use of banned substances and sport supplements, greater intentions to stay clean, and will also show improvements in the cognitive and motivational antecedents to doping when compared to a control condition.

Conditions

  • Doping in Sport
  • Performance Enhancing Product Use

Interventions

BEHAVIORAL

Videogame

True Champion is an educational, values-based game that aims to empower young athletes to make informed decisions to avoid doping. Participants engaging in the videogame sessions will encounter a series of thought-provoking situations and knowledge tests. Players will help their assigned character navigate through these curriculum-rich scenarios in order to reach their performance goals in a healthy and ethical way.

BEHAVIORAL

Control

Participants will be given an anti-doping booklet prepared by UNESCO. This booklet is considered standard educational material, i.e. what might be presented to young athletes as part of their regular sports curriculum.

Sponsors & Collaborators

Principal Investigators

  • Lindsay R Duncan, PhD · McGill University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-12-31
Completion
2022-06-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04203992 on ClinicalTrials.gov